Report for O'Neill MJ

General

Full name : O'Neill Michael J

First name : Michael J

Mail : Lilly UK, Erl Wood Manor, Windlesham, Surrey GU20 6PH

Zip Code :

City :

Country : United Kingdom

Email :

Phone :

Fax :

Website :

Directory :

References (10)

Title : Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders - Bruns_2017_Neuropharmacol_128_351
Author(s) : Bruns RF , Mitchell SN , Wafford KA , Harper AJ , Shanks EA , Carter G , O'Neill MJ , Murray TK , Eastwood BJ , Schaus JM , Beck JP , Hao J , Witkin JM , Li X , Chernet E , Katner JS , Wang H , Ryder JW , Masquelin ME , Thompson LK , Love PL , Maren DL , Falcone JF , Menezes MM , Zhang L , Yang CR , Svensson KA
Ref : Neuropharmacology , 128 :351 , 2017
Abstract : Bruns_2017_Neuropharmacol_128_351
ESTHER : Bruns_2017_Neuropharmacol_128_351
PubMedSearch : Bruns_2017_Neuropharmacol_128_351
PubMedID: 29102759

Title : AMPA receptor potentiators as cognitive enhancers - O'Neill_2007_IDrugs_10_185
Author(s) : O'Neill MJ , Dix S
Ref : IDrugs , 10 :185 , 2007
Abstract : O'Neill_2007_IDrugs_10_185
ESTHER : O'Neill_2007_IDrugs_10_185
PubMedSearch : O'Neill_2007_IDrugs_10_185
PubMedID: 17351873

Title : Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat - Visanji_2006_Neuropharmacol_50_36
Author(s) : Visanji NP , Mitchell SN , O'Neill MJ , Duty S
Ref : Neuropharmacology , 50 :36 , 2006
Abstract : Visanji_2006_Neuropharmacol_50_36
ESTHER : Visanji_2006_Neuropharmacol_50_36
PubMedSearch : Visanji_2006_Neuropharmacol_50_36
PubMedID: 16153666

Title : 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta - Hanrott_2006_J.Biol.Chem_281_5373
Author(s) : Hanrott K , Gudmunsen L , O'Neill MJ , Wonnacott S
Ref : Journal of Biological Chemistry , 281 :5373 , 2006
Abstract : Hanrott_2006_J.Biol.Chem_281_5373
ESTHER : Hanrott_2006_J.Biol.Chem_281_5373
PubMedSearch : Hanrott_2006_J.Biol.Chem_281_5373
PubMedID: 16361258

Title : Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes - Jones_2006_J.Mol.Neurosci_30_83
Author(s) : Jones IW , Westmacott A , Chan E , Jones RW , Dineley K , O'Neill MJ , Wonnacott S
Ref : Journal of Molecular Neuroscience , 30 :83 , 2006
Abstract : Jones_2006_J.Mol.Neurosci_30_83
ESTHER : Jones_2006_J.Mol.Neurosci_30_83
PubMedSearch : Jones_2006_J.Mol.Neurosci_30_83
PubMedID: 17192639

Title : Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle - Visanji_2006_Neuropharmacol_51_506
Author(s) : Visanji NP , O'Neill MJ , Duty S
Ref : Neuropharmacology , 51 :506 , 2006
Abstract : Visanji_2006_Neuropharmacol_51_506
ESTHER : Visanji_2006_Neuropharmacol_51_506
PubMedSearch : Visanji_2006_Neuropharmacol_51_506
PubMedID: 16814329

Title : Alpha bungarotoxin-1.4 nm gold: a novel conjugate for visualising the precise subcellular distribution of alpha 7* nicotinic acetylcholine receptors - Jones_2004_J.Neurosci.Methods_134_65
Author(s) : Jones IW , Barik J , O'Neill MJ , Wonnacott S
Ref : Journal of Neuroscience Methods , 134 :65 , 2004
Abstract : Jones_2004_J.Neurosci.Methods_134_65
ESTHER : Jones_2004_J.Neurosci.Methods_134_65
PubMedSearch : Jones_2004_J.Neurosci.Methods_134_65
PubMedID: 15102504

Title : SMi 4th Annual Conference on Neurodegenerative Disorders: a focus on Alzheimer's and Parkinson's disease - O'Neill_2004_Expert.Opin.Investig.Drugs_13_1369
Author(s) : O'Neill MJ
Ref : Expert Opin Investig Drugs , 13 :1369 , 2004
Abstract : O'Neill_2004_Expert.Opin.Investig.Drugs_13_1369
ESTHER : O'Neill_2004_Expert.Opin.Investig.Drugs_13_1369
PubMedSearch : O'Neill_2004_Expert.Opin.Investig.Drugs_13_1369
PubMedID: 15461566

Title : The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration - O'Neill_2002_Curr.Drug.Targets.CNS.Neurol.Disord_1_399
Author(s) : O'Neill MJ , Murray TK , Lakics V , Visanji NP , Duty S
Ref : Curr Drug Targets CNS Neurol Disord , 1 :399 , 2002
Abstract : O'Neill_2002_Curr.Drug.Targets.CNS.Neurol.Disord_1_399
ESTHER : O'Neill_2002_Curr.Drug.Targets.CNS.Neurol.Disord_1_399
PubMedSearch : O'Neill_2002_Curr.Drug.Targets.CNS.Neurol.Disord_1_399
PubMedID: 12769612

Title : Pharmacological approaches to disease-modifying therapies in Parkinson's disease - O'Neill_2002_Expert.Rev.Neurother_2_819
Author(s) : O'Neill MJ , Siemers ER
Ref : Expert Rev Neurother , 2 :819 , 2002
Abstract : O'Neill_2002_Expert.Rev.Neurother_2_819
ESTHER : O'Neill_2002_Expert.Rev.Neurother_2_819
PubMedSearch : O'Neill_2002_Expert.Rev.Neurother_2_819
PubMedID: 19810916